Olaparib is a prescription medication that has shown promise in the treatment of certain types of cancer. Specifically, Olaparib belongs to a class of drugs known as PARP inhibitors and is used to treat ovarian, fallopian tube and primary peritoneal cancer. By blocking the activity of an enzyme called PARP, which helps repair damaged DNA in cells, Olaparib can selectively target and eliminate cancer cells. This targeted approach to cancer treatment is an exciting development in the fight against cancer and has the potential to improve treatment outcomes for patients.
Let us go through the questions and answers below for easy understanding!
- What is Olaparib?
Olaparib is a prescription medication that belongs to a class of drugs known as PARP inhibitors.
PARP inhibitors work by blocking the activity of an enzyme called PARP, which helps repair damaged DNA in cells.
- What is Olaparib used for?
Olaparib is used to treat certain types of cancer, including ovarian cancer, fallopian tube cancer, and primary peritoneal cancer.
It is often used as a maintenance therapy to help prevent cancer from coming back after treatment.
Olaparib is typically used after a patient has already undergone treatment with chemotherapy.
- How does Olaparib work?
When cancer cells have a mutation in the BRCA1 or BRCA2 genes, they become unable to repair DNA damage effectively. This can make them more vulnerable to the effects of PARP inhibitors like Olaparib.
By blocking PARP activity, Olaparib can help prevent cancer cells from repairing damaged DNA, ultimately leading to their death.
- How is Olaparib taken?
Olaparib is taken orally in capsule form.
The dosage and duration of treatment may vary depending on the patient’s individual circumstances and the type of cancer being treated.
- What are the side effects of Olaparib?
Like all medications, Olaparib can cause side effects, and patients should talk to their doctor about the potential benefits and risks of taking this drug.
Common side effects of Olaparib include nausea, fatigue, vomiting and anemia.
Patients may also experience more serious side effects, such as allergic reactions, or an increased risk of developing certain types of cancer.
Read More: https://www.bbc.com/news/health-65188865